ReviewDiabetologia2026
Development and application of type 1 diabetes polygenic scores across diverse populations.
Review in Diabetologia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Type 1 diabetes is highly influenced by genetic risk factors, especially variation in the HLA genes. Polygenic scores can strongly predict type 1 diabetes risk by integrating variants across the genome. Most polygenic scores perform best in European-ancestry populations, due to low representation of other ancestry groups in existing studies, as well as substantial variation in HLA alleles across the globe. However, recent multi-ancestry genome-wide association studies have broadened our understanding of type 1 diabetes genetic risk, and advanced computational techniques can accurately capture HLA alleles at high resolution. This article will review novel approaches to develop type 1 diabetes polygenic scores that demonstrate high predictive power across diverse populations.
Indexed as
Identifiers
42587193What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.